drugset / Trial / NCT00241839

Uric Acid and Hypertension in African Americans

NCT00241839

Phase 3 Completed 150 enrolled University of Florida
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test the hypothesis that the administration of a xanthine oxidase inhibitor (allopurinol) will prevent thiazide-induced hyperuricemia, which will result in better blood pressure (BP) control in African Americans.

Timeline

Start
2005-08
Primary completion
2011-05
Completion
2011-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule 300 mg
Comparator Allopurinol Small molecule 600 mg
Comparator Chlorthalidone Other / unclassified 25 mg
Comparator Potassium Chloride Small molecule 50 meq